Related by context. All words. (Click for frequent words.) 72 Allovectin 7 72 oral ridaforolimus 71 alvespimycin 71 Bicifadine 71 PLK1 SNALP 71 vosaroxin 70 HGS# 70 Tocosol Paclitaxel 70 ganetespib 70 forodesine 70 Panzem R NCD 69 IMC #B 69 HGS ETR2 69 MOZOBIL 69 ApoB SNALP 69 XL# XL# XL# XL# 69 TOCOSOL 69 Allovectin 7 R 69 Phase #b/#a clinical 68 Surfaxin LS 68 tezampanel NGX# 68 oral prodrug 68 TOCOSOL Camptothecin 68 CoFactor 68 OncoVEX GM CSF 68 elotuzumab 68 lintuzumab 68 deforolimus 68 pradefovir 68 TKM ApoB 68 dacetuzumab 68 HGS ETR1 68 talactoferrin 68 INT# [002] 68 CR# vcMMAE 68 confirmatory Phase III 68 PEG SN# 68 OvaRex R 68 Asentar 67 Archexin 67 Syncria 67 MAGE A3 ASCI 67 AeroLEF TM 67 Exelixis compounds 67 ruxolitinib 67 HepeX B 67 AQ4N 67 Phase IIb trials 67 #D#C# 67 PDE4 inhibitor 67 TELINTRA 67 BLA filing 67 ularitide 67 otelixizumab 67 HuLuc# 67 IMA# 67 Bezielle 67 YONDELIS 67 ASONEP 67 MAXY G# 67 Stedivaze 67 torezolid phosphate 67 oral taxane 67 ridaforolimus 67 Kosan dependence 67 Allovectin 7 r 67 HuMax CD4 67 MyVax R 67 IV APAP 67 MAXY alpha 67 PXD# 67 Insegia 67 LEP ETU 66 Viramidine 66 Troxatyl 66 DPX Survivac 66 ELADUR 66 Stimuvax R 66 tanespimycin 66 liprotamase 66 eniluracil 66 EOquin TM 66 Prednisporin TM 66 pralatrexate 66 EOquin 66 HCD# [002] 66 OvaRex ® MAb 66 R#/MEM # 66 NGX# 66 Phase 1b trial 66 INCB# [001] 66 JAK inhibitor 66 Nasulin 66 PHX# 66 IND submission 66 Civacir 66 enzastaurin 66 PREOS R 66 radiation sensitizer 66 midstage trials 66 Omigard 66 NEBIDO 66 Zerenex 66 M Enoxaparin 66 selective androgen receptor modulator 66 elagolix 66 preclinical studies 66 oral methylnaltrexone 66 phase IIb 66 GLP toxicology studies 66 phase IIb clinical 66 rALLy trial 66 Ixempra 66 PNP inhibitor 66 MAA submission 66 orBec 66 entinostat 66 tezampanel 65 Alzhemed TM 65 MethyPatch 65 LibiGel ® 65 romidepsin 65 Panitumumab 65 successfully commercialize Iluvien 65 axitinib 65 Allovectin 7 ® 65 custirsen 65 EpiCept NP 1 65 RGB # 65 XP# XP# 65 XL# anticancer compounds 65 ALN VSP 65 NVA# 65 Azedra 65 phase IIb trial 65 MEK inhibitors 65 obatoclax 65 phase IIa clinical 65 Amigal 65 atacicept 65 ISTODAX 65 Varespladib 65 paclitaxel Taxol ® 65 PANVAC VF 65 Virulizin R 65 investigational humanized monoclonal antibody 65 EndoTAG TM -1 65 mertansine 65 midstage clinical 65 XL# XL# 65 vernakalant oral 65 OncoVEX 65 Cloretazine ® 65 Menerba 65 OXi# 65 KNS # 65 PRT# 65 AEG# 65 Intravenous CP 65 anidulafungin 65 ELND# 65 registrational 65 oral picoplatin 65 trastuzumab DM1 65 valopicitabine NM# 65 Canvaxin 65 HuMax EGFr 65 CCR9 antagonist 65 GALNS 65 Panzem R 65 PSMA ADC 65 SAR# [004] 65 Urocidin 65 celgosivir 65 CCX# 65 PROVENGE ® 65 Tarceva TM 65 GnRH antagonist 65 Phase IIb clinical trials 65 IoGen 65 PRECISE trial 64 evaluating satraplatin 64 LibiGel Phase III 64 Neo Kidney Augment 64 SILENOR 64 MYDICAR ® 64 leading oral taxane 64 OMNARIS HFA 64 TRANSDUR Sufentanil 64 Phase 2a clinical trials 64 Marqibo 64 nonclinical studies 64 Pimavanserin 64 HuMax TAC 64 Neo Kidney Augment ™ 64 Sular formulation 64 XmAb# 64 neratinib 64 tremelimumab 64 forodesine hydrochloride 64 ESTRASORB 64 ProSavin 64 GED aPC 64 TBC# 64 NV1FGF 64 tivozanib 64 Genz # 64 synthetic retinoid 64 valopicitabine 64 lintuzumab SGN 64 CINTREDEKIN BESUDOTOX 64 LE SN# 64 T Pred 64 trastuzumab DM1 T DM1 64 PEG PAL 64 FOLOTYN ® 64 Alnylam #x# 64 DAVANAT 64 Phase IIIb clinical 64 Ketotransdel 64 LEUKINE 64 L BLP# 64 R sorafenib tablets 64 PSN# [002] 64 anticancer compound 64 Aflibercept 64 candidate AQ4N 64 Chemophase 64 Mipomersen 64 ZOLINZA 64 OMNARIS Nasal Spray 64 faropenem 64 nalbuphine ER 64 Azixa 64 Anthim 64 brentuximab vedotin SGN 64 Xcytrin R 64 Neo Urinary Conduit 64 Pradefovir 64 TELCYTA 64 DXL# 64 SUCCEED trial 64 THALOMID 64 Phase Ib study 64 panitumumab Vectibix 64 TKM PLK1 64 ZEGERID Capsules 64 Nanobody 64 budiodarone 64 Solazed TM 64 Personalized Immunotherapy 64 amrubicin 64 Myocet 64 Anturol TM 64 Perifosine 64 EFAPROXYN 64 PROMACTA 64 rhThrombin 64 Phase IIa clinical trials 64 GVAX ® 64 EndoTAG TM 64 adecatumumab MT# 64 Xanafide 64 LE DT 64 glucokinase activator 64 oxymorphone ER 64 R#/MEM 64 IMC A# 64 Phase #b/#a 64 Glufosfamide 64 dextofisopam 64 Trizytek 64 Synavive 64 ZK EPO 64 LY# [003] 64 Nanobody ® 64 Androxal TM 64 Omigard TM 64 isoform selective 64 Cleviprex TM clevidipine 64 Quinamed 64 MGCD# [001] 64 Sulonex TM 64 AERx iDMS 64 evaluating tivozanib 64 belinostat 64 ponatinib 64 personalized immunotherapy 64 Eligard R 64 ospemifene 64 Relivar 63 liposomal formulation 63 UPLYSO 63 Solazed 63 compound INCB# 63 cystinosis patients 63 daclizumab 63 teduglutide 63 Mepact 63 CORLUX CORT # 63 MYDICAR 63 AZILECT R 63 WILEX 63 Targretin 63 lumiliximab 63 Nasulin ™ 63 Aurora kinase inhibitor 63 metaglidasen 63 Prestara 63 THR beta agonist 63 Phase IIa trials 63 SILENOR TM 63 Belinostat 63 Probuphine 63 Lamictal ODT 63 Phase 1a clinical 63 JAK2 inhibitor 63 BrachySil 63 Trofex TM 63 Pazopanib 63 Zelrix 63 SNS# T 63 TRISENOX 63 Romidepsin 63 initiate Phase IIb 63 BioVant 63 Topical Interferon Alpha 2b 63 Sym# 63 vidofludimus 63 octreotide implant 63 UVIDEM 63 DCVax R 63 cannabinor 63 ATryn ® 63 velafermin belinostat 63 Phase Ib II 63 lomitapide 63 vilazodone 63 pertuzumab 63 Dextofisopam 63 RhuDex ® 63 Genaera 63 Hybridon 63 SinuNase ™ 63 Plicera 63 Annamycin 63 eltrombopag 63 Technosphere Insulin 63 CRMD# 63 PRECISE Trial 63 cancer immunotherapies 63 FM VP4 63 Tezampanel 63 GRN# 63 ALN PCS 63 EP #R 63 Selective Electrochemical Tumor Ablation 63 candidate CRLX# 63 Trofex 63 elacytarabine 63 Virulizin ® 63 indibulin 63 dalbavancin 63 CB2 selective receptor agonist 63 KRN# 63 tecarfarin 63 subcutaneous formulation 63 Zensana 63 Canvaxin TM 63 Lucanix R 63 Hedgehog antagonist 63 Poly ICR 63 Phase III LibiGel 63 MBP# [001] 63 Synavive ™ 63 Zemiva TM 63 regorafenib 63 CRLX# 63 HuMax CD# 63 lapatinib Tykerb 63 TYZEKA 63 ENRICH trial 63 DR Cysteamine 63 BEMA TM Fentanyl 63 incyclinide 63 HQK 63 phase IIb III 63 novel histone deacetylase 63 huC# DM4 63 Eligard ® 63 Entereg R 63 IIa trial 63 rALLy clinical trial 63 Angiocept 63 Rotarix ® 63 initiate Phase 1b 63 Exalgo 63 Zingo TM 63 Phase 2a trial 63 Egrifta 63 Theratope 63 OvaRex 63 aleglitazar 63 oral talactoferrin 63 IL# PE#QQR 63 Ophena TM 63 Acetavance 63 Amrubicin 63 Novolimus 63 Panzem 63 Phase Ib 63 Phase 2b clinical trials 63 adipiplon 63 LibiGel transdermal testosterone gel 63 tafamidis 63 TAFA# 63 dirucotide 63 confirmatory Phase 3 63 MAXY VII 63 Valortim 63 oral salmon calcitonin 63 PrevOnco 63 refractory PTCL 63 investigational monoclonal antibody 63 ATL# [001] 63 Genasense ® oblimersen 63 BRAF inhibitor 63 rindopepimut 63 omacetaxine 63 GVAX R 63 orally bioavailable 63 epothilone 63 SNALP technology 63 BCX# 63 ocrelizumab 63 HspE7 62 SonoLysis 62 candidate deforolimus 62 KIACTA ™ 62 PDX pralatrexate 62 OncoGel 62 NEUMUNE 62 picoplatin 62 PEG Interferon lambda 62 Vitaxin 62 Fodosine 62 AIMM trial 62 registrational trial 62 Icatibant 62 ixabepilone 62 Protexia ® 62 tiapamil 62 Targeted Chemotherapy 62 telomerase therapeutic 62 BZL# 62 Evoltra ® 62 Ceplene 62 FavId 62 bicifadine 62 Vectibix panitumumab 62 Potelligent Technology 62 Anturol 62 Aplidin 62 IRX 2 62 Argatroban 62 Uvidem 62 MAb therapy 62 Exelbine 62 Frova ® 62 IAP inhibitors 62 apricitabine ATC 62 CDP# 62 XL# XL# XL# 62 FOLOTYN 62 BAY #-# 62 Adentri 62 INTEGRILIN R eptifibatide Injection 62 Hematide ™ 62 DOS# 62 zileuton CR 62 DexaSite 62 Orazol 62 omega interferon 62 sorafenib Nexavar 62 StaphVAX 62 bazedoxifene 62 maximally tolerated dose 62 atrasentan 62 Epothilones 62 Thalomid ® 62 Pruvel 62 MoxDuo IR 62 ulimorelin 62 Zensana TM 62 Vilazodone 62 reslizumab 62 Azedra TM 62 AeroLEF R 62 Phenoptin 62 cetuximab Erbitux 62 RAPTIVA 62 orBec R 62 Seliciclib 62 Prednisporin 62 oncolytic virus therapies 62 PS# [001] 62 PREOS 62 HCV protease inhibitor 62 cangrelor 62 Nexavar ® 62 acyclovir Lauriad R 62 squalamine 62 CEQ# 62 virus HCV protease inhibitor 62 AAG geldanamycin analog 62 ONCONASE 62 aflibercept 62 RAPTIVA R 62 aplindore 62 JZP 62 Dyloject TM 62 ASA# 62 KRYSTEXXA TM pegloticase 62 Tyrima 62 novel anticancer 62 docetaxel Taxotere ® 62 CORT # 62 Laquinimod 62 IMGN# 62 pexelizumab 62 methylnaltrexone 62 AMEVIVE 62 NicVAX 62 Harbor BioSciences 62 Traficet EN 62 Rebif ® 62 Chimigen TM 62 SinuNase TM 62 AzaSite Plus 62 ARIKACE ™ 62 Talabostat 62 Phase #/#a 62 EGS# 62 ofatumumab 62 APEX PD 62 PrevOnco ™ 62 maribavir 62 Orathecin 62 ONTAK 62 Neurodex 62 StaphVAX R 62 Cellegesic 62 SPRYCEL ® 62 GAP #B# 62 QTinno TM 62 punctal plug 62 fund BioSante LibiGel 62 anti EGFR antibody 62 ITAX 62 Folotyn 62 Genitope Corporation 62 Octreotide 62 Vaxfectin TM 62 ongoing Phase IIIb 62 Ophena 62 Pralatrexate 62 Fibrillex TM 62 BEMA Granisetron 62 Tesetaxel 62 uric acid lowering 62 AP# [003] 62 Cintredekin Besudotox 62 Soliris TM eculizumab 62 OPAXIO 62 Daclizumab 62 olaparib 62 TOLAMBA 62 ALN RSV# 62 mapatumumab 62 Ziopharm 62 Cloretazine R VNP#M 62 JAK1 62 Exherin 62 zanolimumab 62 preclinical 62 voreloxin 62 ATL/TV# 62 docetaxel Taxotere R 62 Onalta ™ 62 ATryn R 62 Duromist ™ 62 therapeutic monoclonal antibody 62 MEND CABG II 62 systemic immunosuppressive drugs 62 Targretin capsules 62 XL# [003] 62 Marqibo TM 62 LentiVector technology 62 Iluvien ® 62 Nuvion 62 Loramyc R 62 CYC# 62 Onco TCS 62 Phase Ib clinical 62 seliciclib CYC# 62 urocortin 2 62 Ariad Pharma 62 Proxinium TM 62 class mGluR5 inhibitor 62 preclinically 62 MDV# 62 G#DT 62 PRX # 62 motexafin gadolinium Injection 62 Azedra ™ 62 glufosfamide 62 velafermin 62 tesmilifene 62 NitroMist TM 62 mTOR kinase 62 Davanat 62 Xinlay 62 Plenaxis TM 62 tramiprosate Alzhemed TM 62 ELACYT 62 Neuradiab 62 DU #b 62 Zemplar Capsules 62 Advaxis Phase 62 Phase 1b clinical trials 62 Presents Preclinical 62 ENMD # 62 Mpex 62 VALSTAR 62 RIGScan CR 62 Acetavance TM 62 Memryte 62 Lupuzor 62 cinacalcet HCl 62 Saforis 62 severe hypercholesterolemia 62 refractory chronic lymphocytic 62 initiated Phase Ib 62 Velcade bortezomib 62 Daniel Junius 62 Factor VIIa 62 Fentanyl Taifun 62 Æterna Zentaris 62 PF # [002] 62 Omapro 62 Taxotere chemotherapy 62 systemic RNAi 61 LymphoStat B TM 61 naronapride 61 Panzem NCD 61 teriflunomide 61 Troxatyl TM 61 ZADAXIN ® 61 sNDA submission 61 Lauren Silvernail 61 R roscovitine 61 Ereska 61 targeted radiotherapeutic 61 Hyphanox 61 BrachySil TM 61 Hedgehog agonist 61 FluINsure 61 ONCONASE R 61 candidate TNFerade biologic 61 tolevamer 61 Actimmune ® 61 CAMPATH 61 Proellex TM 61 HepeX B TM 61 AZD# TC 61 APF# 61 CCR5 mAb 61 lesinurad 61 Lumacan 61 Viprinex TM 61 Sulonex 61 Bellicum 61 inhaled formulation 61 Evamist TM 61 NovaDel 61 TRACON Pharmaceuticals 61 Ramoplanin 61 Altastaph 61 candidate REP# 61 Telatinib 61 sodium Injection 61 AVP #D# 61 TRANSDUR Bupivacaine 61 initiate Phase 2a 61 DAVANAT ® 61 CIMZIA ™ 61 Mr. Bentsur 61 alvimopan 61 budesonide MMX Phase III 61 highly purified pasteurized 61 Maribavir 61 visit biotech.com 61 Tanespimycin 61 Numoda 61 mifamurtide 61 MEK Inhibitor 61 Intraject 61 Vandetanib 61 Phase 2a clinical 61 EGRIFTA TM 61 OHR/AVR# 61 molecular imaging radiopharmaceutical 61 Fortical R 61 Tykerb lapatinib 61 TLR9 agonist 61 CIP TRAMADOL ER 61 Onrigin 61 HSP# inhibitor 61 Tocosol 61 PhosLo 61 Triolex 61 generation URAT1 inhibitor 61 Capesaris 61 enoximone 61 Onconase 61 Nanobody R 61 proprietary transdermal patch 61 ESTRASORB R 61 antibody MAb 61 Genasense ® 61 Elotuzumab 61 volociximab 61 bafetinib 61 drug conjugate 61 non nucleoside HCV 61 candidate XP# 61 MGN# 61 TRO# 61 DCVax R Brain 61 Oasmia 61 StemEx R 61 AVAX 61 Corlux 61 Inhalation Solution 61 platforms GVAX 61 Zenvia ™ 61 URG# 61 EVIZON TM 61 ZYBRESTAT 61 next generation URAT1 61 5 HT3 antagonist 61 DCVax R Prostate 61 Bioral 61 mipomersen 61 Firazyr 61 Phase Ib clinical trials 61 Tamibarotene 61 vinorelbine emulsion 61 rhMBL 61 Phase #b/#a trial 61 Dacogen injection 61 Zavesca r 61 Aegerion 61 Xeloda ® 61 Flutiform TM 61 Elestrin 61 Sanctura XR 61 Excellarate 61 vaccines oncolytic virus 61 Zolinza 61 prGCD 61 Nebido 61 Gemzar ® 61 MEK inhibitor RDEA# 61 Elagolix 61 pharmacokinetic PK study 61 oral PTH 61 Oral NKTR 61 FUSILEV ® 61 OMAPRO 61 Clonicel 61 telomerase inhibitor drug 61 apaziquone 61 CBLC# 61 Proquin XR 61 Amplimexon 61 Zoraxel 61 DermaVir Patch 61 autoimmune indications 61 evaluating bafetinib 61 CONBRIZA 61 orally administered inhibitor 61 PREGNANT Study 61 Hsp# Inhibitor 61 please visit www.advaxis.com 61 Myrexis 61 BiTE antibody 61 multi kinase inhibitor 61 Androxal ® 61 ThermoDox ® clinical 61 BioSante licensees 61 InterfeRx 61 HCV protease inhibitors 61 ADVENTRX 61 dasatinib Sprycel 61 BLA submission 61 hepatitis C protease inhibitor 61 IMPDH inhibitor 61 fostamatinib 61 Exenatide LAR 61 NDA resubmission 61 human IgG1 monoclonal 61 NeuroVax TM 61 brostallicin 61 Aganocide 61 LEVADEX ™ 61 Neulasta ® 61 POSIDUR TM 61 PolyActive ® 61 SILENOR ™ 61 phase Ib 61 VitiGam 61 Strativa 61 GRNVAC1 61 Emselex 61 Celladon Corporation 61 HEPLISAV 61 LHRH antagonists 61 panitumumab 61 tubulin inhibitor 61 PEGylated interferon 61 cladribine tablets 61 sunitinib malate 61 taribavirin 61 Shigamabs R 61 TroVax ® 61 AEGR 61 CLIRS trial 61 Alnara 61 Cetrorelix 61 Asentar TM 61 XL# SAR# 61 SUTENT ® 61 MyVax ® 61 Shigamabs ® 61 TRISENOX R 61 QNEXA 61 sumatriptan DosePro 61 dutogliptin 61 Campath alemtuzumab 61 initiate Phase 2b 61 Abiraterone acetate 61 ostarine 61 tamibarotene 61 SARMs 61 Vaxfectin 61 RSD# 61 Tarvacin Anti Cancer 61 Bionutrics 61 Genentech Herceptin 61 intranasal insulin product 61 EVIZON TM squalamine lactate 61 EndoTAG 61 LibiGel ® testosterone gel 61 LymphoStat B belimumab 61 BRIM3 61 GRN#L 61 candidate Zenvia 61 L DOS# 61 Clavis Pharma 61 Dalbavancin 61 Opexa 61 ISIS # 61 Xyotax 61 opioid induced bowel dysfunction 61 HuCAL antibodies 61 OMS#HP 61 RLY# 61 Enjuvia 61 cetuximab Erbitux R 61 EDEMA3 61 CA4P 61 triphendiol 61 Cerashield 61 Arranon 61 AZILECT ® 61 ABILIFY ® 61 Thorough QT 61 phase 2a 61 small molecule tyrosine 61 AzaSite TM 61 lasofoxifene 61 prostone 61 interferon gamma 1b 61 TREANDA 61 Dr. Fahar Merchant 61 IND enabling 61 CYT# potent vascular disrupting 61 Phenserine 61 TKM Ebola 61 BioSante LibiGel Phase III 61 ABRAXANE TM 61 Anturol ® 61 Initiates Phase III 61 Symadex 61 TMC# [002] 61 CaPre TM 61 sapacitabine 61 Zelapar 60 Veronate 60 TRISENOX ® 60 VEGF Trap 60 tasimelteon 60 Phase lll 60 Bioral Amphotericin B. 60 Phase 2b study 60 Xcellerated T Cells 60 Relovair 60 SNT MC# 60 HEPLISAV TM 60 favorable pharmacokinetic profile 60 paclitaxel Taxol R 60 Triapine 60 PROSTVAC VF 60 Chrysalin 60 pomalidomide 60 generation purine nucleoside 60 Phase III clinical 60 Unit Dose Budesonide 60 Orapred ODT 60 TransVax tm 60 inhaled AAT 60 CD# CEA 60 Pivotal Phase III 60 Zybrestat 60 ProMune 60 Vicinium TM 60 Cerimon 60 CCR5 antagonist 60 Phase 1b clinical 60 Urocortin 2 60 epigenetic therapies 60 RSD# oral 60 Aerosurf 60 QVA# 60 Besivance 60 thymalfasin 60 SERMs 60 ORENCIA R 60 lenalidomide Revlimid R 60 Locteron ® 60 FACTIVE tablets 60 Clolar ® 60 SinuNase 60 hoFH 60 Prestara TM 60 Telintra 60 phase IIa 60 Phase III Pivotal 60 candidate epratuzumab 60 MGd 60 UltiMAb 60 dextromethorphan quinidine 60 BNC# 60 cobiprostone 60 Reverset 60 BENLYSTA 60 ongoing Phase 1b 60 non nucleoside polymerase 60 HDL Selective Delipidation 60 MT#/MEDI-# 60 perifosine 60 metastatic sarcomas 60 Lovaza TM 60 subcutaneous Herceptin 60 BEXXAR 60 budesonide foam 60 pegloticase 60 recombinant biopharmaceutical 60 outlicensing 60 SPARLON 60 FTY# 60 ARRY # 60 ocular formulation 60 VersaFilm 60 IDX# 60 JNJ Q2 60 immunotherapeutic vaccine 60 Completes Patient Enrollment 60 Pertuzumab 60 PI3K/Akt pathway inhibitor 60 Aurexis 60 Vicriviroc 60 palifosfamide Zymafos TM 60 ADP receptor antagonist 60 orally dosed 60 AGGRASTAT ® 60 NP2 Enkephalin 60 Exherin TM